Compounds > org gc 94
Page last updated: 2024-09-04

org gc 94 and Migraine Disorders

org gc 94 has been researched along with Migraine Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pfeifer, Y; Sulman, FG; Superstine, E1
Hardebo, JE; Lamar, JC1
Bhargava, N; Matthijsen, R; Schönbaum, E1

Trials

1 trial(s) available for org gc 94 and Migraine Disorders

ArticleYear
Preventive treatment of serotonin-migraine with 1,3,4,14b-tetrahydro-2,7-dimethyl-2H-dibenzo(b,f)pyrazino-(1,2--d)-(1,4)-oxazepine hydrogen maleate (Org GC 94). A double-blind study.
    Arzneimittel-Forschung, 1981, Volume: 31, Issue:1

    Topics: Adult; Aged; Clinical Trials as Topic; Dibenzoxazepines; Double-Blind Method; Female; Hormones; Humans; Male; Middle Aged; Migraine Disorders; Serotonin

1981

Other Studies

2 other study(ies) available for org gc 94 and Migraine Disorders

ArticleYear
Interaction of a potential antimigraine drug (Org GC 94) with the vasomotor action of serotonin.
    European journal of pharmacology, 1979, Dec-20, Volume: 60, Issue:4

    Topics: Animals; Arteries; Dibenzoxazepines; Dogs; Female; In Vitro Techniques; Male; Migraine Disorders; Nasal Mucosa; Regional Blood Flow; Serotonin; Serotonin Antagonists; Species Specificity; Vasoconstriction

1979
Some effects of ORG GC 94, a potential anti-migraine drug, on human platelets.
    European journal of pharmacology, 1977, Apr-07, Volume: 42, Issue:3

    Topics: Blood Platelets; Cell Membrane; Dibenzoxazepines; Humans; In Vitro Techniques; Migraine Disorders; Monoamine Oxidase; Platelet Aggregation; Serotonin; Time Factors

1977